Skip to main content
Figure 1 | BMC Ophthalmology

Figure 1

From: Individualized ranibizumab therapy strategies in year 3 after as-needed treatment for polypoidal choroidal vasculopathy

Figure 1

Improvement in the logarithm of the minimum angle of resolution (logMAR) visual acuity (VA) at the end of the third year in each treatment schedule. The white and shaded bars indicate the changes from baseline and the 2-year values, respectively. The positive values on the Y-axis indicate VA improvements at the end of the third year compared to baseline or 2 years. PRN = pro re nata. *P = 0.01; †P = 0.04; ‡P = 0.02.

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us